ORGO · Organogenesis Holdings Inc. · Share Buybacks
$0.81
+0.02 (+2.31%)
At close · Nov 20
Return incl. dividend (before tax)
Play latest call
Q3 2026 earnings call transcript
Market Cap
$102.44M
Shares
129.80M
Volume · Nov 20
233.32K
Avg daily vol (3M)
845.21K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.
Equity Offering (ATM) Programs
| Program Established | Last Amended | Capacity | Remaining | Runs Through | Source |
|---|---|---|---|---|---|
| 2026-08-06 | — | $75,000 | — | — | 10-Q , filed 2026-11-05 |
Repurchase History
| Fiscal Year Ended | Cash Spent | Source | ||
|---|---|---|---|---|
| 2024-12-31 | $25,479,000 | 10-K, filed 2026-02-26 | ||
Key facts
CIK
1661181
CUSIP
68621F102
13F (30d)
128 filings
112 filers
Visit website
Investor relations